IDR 51.0
(2.0%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 978.07 Million IDR | 75.42% |
2022 | -5.1 Billion IDR | -163.27% |
2021 | 34.57 Billion IDR | 2.32% |
2020 | 33.79 Billion IDR | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | -1.31 Billion IDR | -19.37% |
2024 Q1 | -1.1 Billion IDR | 48.16% |
2023 Q2 | -5.59 Billion IDR | -694.95% |
2023 FY | - IDR | 75.42% |
2023 Q1 | 940.34 Million IDR | 0.0% |
2022 FY | - IDR | -163.27% |
2021 FY | - IDR | 2.32% |
2020 FY | - IDR | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
PT Mark Dynamics Indonesia Tbk | 234.35 Billion IDR | 99.583% |
PT Hetzer Medical Indonesia Tbk | 1.22 Billion IDR | 20.342% |
PT Jayamas Medica Industri Tbk | 371.38 Billion IDR | 99.737% |